Market Cap 8.09B
Revenue (ttm) 6.56B
Net Income (ttm) 1.01B
EPS (ttm) N/A
PE Ratio 7.92
Forward PE 7.90
Profit Margin 15.37%
Debt to Equity Ratio 0.25
Volume 1,008,200
Avg Vol 672,176
Day's Range N/A - N/A
Shares Out 77.04M
Stochastic %K 76%
Beta 0.63
Analysts Sell
Price Target $122.91

Company Profile

AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products in Bermuda, the United States, and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment offers professional insurance products that cover directors' and officers' liability, errors and omissions, employment practices, fiduciary, crime, professional indemnity, medical malpractice, and other financial insurance related coverages for c...

Industry: Insurance - Specialty
Sector: Financial Services
Phone: 441 496 2600
Fax: 441 405 2600
Address:
92 Pitts Bay Road, AXIS House, Pembroke, Bermuda
SueannMall
SueannMall Feb. 22 at 12:31 AM
$CVKD Acquires 12-LOX Inhibitor for the Treatment of Heparin-Induced Thrombocytopenia (HIT) https://scr.zacks.com/news/news-details/2026/CVKD-Acquires-12-LOX-Inhibitor-for-the-Treatment-of-Heparin-Induced-Thrombocytopenia-HIT-article/default.aspx $MNKD $NEAR $MTN $AXS
0 · Reply
ZacksResearch
ZacksResearch Feb. 18 at 2:45 PM
$AXS outperforming industry peers with a 14% rise in the past year! Trading above 50 & 200-day SMAs Strong earnings track record & attractive valuation Analysts' average target price suggests a 20.5% upside potential Discover what makes AXIS Capital a standout in its sector 👉 https://www.zacks.com/stock/news/2871127/axs-outperforms-industry-trades-near-52-week-high-time-to-hold?cid=sm-stocktwits-2-2871127-body-33957&ADID=SYND_STOCKTWITS_TWEET_2_2871127_BODY_33957
0 · Reply
ZacksResearch
ZacksResearch Feb. 18 at 1:45 PM
$AXS is flirting with its 52-week high — but is this a breakout or a breather? AXIS Capital is outperforming the industry, driven by strength across its specialty insurance, reinsurance, and accident and health portfolio. That’s a solid foundation — not hype, but execution. If you’re in it, this might be a disciplined hold, not a chase. See the full risk/reward breakdown 👉 https://www.zacks.com/stock/news/2871127/axs-outperforms-industry-trades-near-52-week-high-time-to-hold?cid=sm-stocktwits-2-2871127-teaser-33932&ADID=SYND_STOCKTWITS_TWEET_2_2871127_TEASER_33932
0 · Reply
Estimize
Estimize Feb. 12 at 1:03 PM
Wall St is expecting 3.44 EPS for $AXS Q1 [Reporting 04/29 AMC] http://www.estimize.com/intro/axs?chart=historical&metric_name=eps&utm_cont
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 9 at 9:05 PM
$AXS Share Price: $103.01 Contract Selected: Sep 18, 2026 $100 Calls Buy Zone: $7.06 – $8.72 Target Zone: $12.31 – $15.04 Potential Upside: 65% ROI Time to Expiration: 220 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
VolControlTrading
VolControlTrading Feb. 4 at 11:56 AM
$AXS is a specialty insurer and reinsurer; its underwriting results are improving in a hard market, but catastrophe exposure remains an earnings volatility risk.
0 · Reply
TitanAssetPartners
TitanAssetPartners Feb. 4 at 11:45 AM
$AXS is an Axis Capital company with a specialty insurance and reinsurance portfolio; its underwriting turnaround is in progress.
0 · Reply
theGreenerGoblin
theGreenerGoblin Feb. 2 at 7:50 PM
$DFNS First $AXS goes on a berserker run these last weeks now $DFNS. My two worst purchases ever have come to life. I feel like I should donate to charity or something.
0 · Reply
50bps
50bps Jan. 28 at 10:33 PM
$AXS headline numbers look strong
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jan. 28 at 9:50 PM
$AXS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $3.73 up 8.75% YoY • Reported revenue of $1.73B up 17.85% YoY
0 · Reply
Latest News on AXS
AXIS Capital Declares Quarterly Dividends

Dec 4, 2025, 4:15 PM EST - 2 months ago

AXIS Capital Declares Quarterly Dividends


AXIS Capital to Present at the 2025 KBW Insurance Conference

Aug 27, 2025, 4:15 PM EDT - 6 months ago

AXIS Capital to Present at the 2025 KBW Insurance Conference


AXIS Announces Chief Financial Officer Transition

Aug 14, 2025, 9:15 AM EDT - 6 months ago

AXIS Announces Chief Financial Officer Transition


AXIS Launches AXIS Capacity Solutions

Aug 13, 2025, 9:00 AM EDT - 6 months ago

AXIS Launches AXIS Capacity Solutions


Close To 7% By AXIS Capital Holdings Limited's Preferred

Aug 5, 2025, 9:00 AM EDT - 7 months ago

Close To 7% By AXIS Capital Holdings Limited's Preferred


AXIS Capital And 7% Yield From Its Preferred Stock

Jun 4, 2025, 1:14 PM EDT - 9 months ago

AXIS Capital And 7% Yield From Its Preferred Stock


AXIS Completes Previously Announced Transaction With Enstar

Apr 24, 2025, 4:05 PM EDT - 10 months ago

AXIS Completes Previously Announced Transaction With Enstar

ESGR


Sara Farrup Becomes AXIS Head of Global Markets

Jan 6, 2025, 8:45 AM EST - 1 year ago

Sara Farrup Becomes AXIS Head of Global Markets


AXIS Capital: A Niche Leader Priced For NOPAT Fall

Dec 22, 2024, 9:00 PM EST - 1 year ago

AXIS Capital: A Niche Leader Priced For NOPAT Fall


AXIS Capital to Host Investor Day on May 30, 2024

May 6, 2024, 4:15 PM EDT - 1 year ago

AXIS Capital to Host Investor Day on May 30, 2024


AXIS Promotes Kyle Freeman to Head of ILS

Mar 21, 2024, 9:00 AM EDT - 2 years ago

AXIS Promotes Kyle Freeman to Head of ILS


SueannMall
SueannMall Feb. 22 at 12:31 AM
$CVKD Acquires 12-LOX Inhibitor for the Treatment of Heparin-Induced Thrombocytopenia (HIT) https://scr.zacks.com/news/news-details/2026/CVKD-Acquires-12-LOX-Inhibitor-for-the-Treatment-of-Heparin-Induced-Thrombocytopenia-HIT-article/default.aspx $MNKD $NEAR $MTN $AXS
0 · Reply
ZacksResearch
ZacksResearch Feb. 18 at 2:45 PM
$AXS outperforming industry peers with a 14% rise in the past year! Trading above 50 & 200-day SMAs Strong earnings track record & attractive valuation Analysts' average target price suggests a 20.5% upside potential Discover what makes AXIS Capital a standout in its sector 👉 https://www.zacks.com/stock/news/2871127/axs-outperforms-industry-trades-near-52-week-high-time-to-hold?cid=sm-stocktwits-2-2871127-body-33957&ADID=SYND_STOCKTWITS_TWEET_2_2871127_BODY_33957
0 · Reply
ZacksResearch
ZacksResearch Feb. 18 at 1:45 PM
$AXS is flirting with its 52-week high — but is this a breakout or a breather? AXIS Capital is outperforming the industry, driven by strength across its specialty insurance, reinsurance, and accident and health portfolio. That’s a solid foundation — not hype, but execution. If you’re in it, this might be a disciplined hold, not a chase. See the full risk/reward breakdown 👉 https://www.zacks.com/stock/news/2871127/axs-outperforms-industry-trades-near-52-week-high-time-to-hold?cid=sm-stocktwits-2-2871127-teaser-33932&ADID=SYND_STOCKTWITS_TWEET_2_2871127_TEASER_33932
0 · Reply
Estimize
Estimize Feb. 12 at 1:03 PM
Wall St is expecting 3.44 EPS for $AXS Q1 [Reporting 04/29 AMC] http://www.estimize.com/intro/axs?chart=historical&metric_name=eps&utm_cont
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 9 at 9:05 PM
$AXS Share Price: $103.01 Contract Selected: Sep 18, 2026 $100 Calls Buy Zone: $7.06 – $8.72 Target Zone: $12.31 – $15.04 Potential Upside: 65% ROI Time to Expiration: 220 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
VolControlTrading
VolControlTrading Feb. 4 at 11:56 AM
$AXS is a specialty insurer and reinsurer; its underwriting results are improving in a hard market, but catastrophe exposure remains an earnings volatility risk.
0 · Reply
TitanAssetPartners
TitanAssetPartners Feb. 4 at 11:45 AM
$AXS is an Axis Capital company with a specialty insurance and reinsurance portfolio; its underwriting turnaround is in progress.
0 · Reply
theGreenerGoblin
theGreenerGoblin Feb. 2 at 7:50 PM
$DFNS First $AXS goes on a berserker run these last weeks now $DFNS. My two worst purchases ever have come to life. I feel like I should donate to charity or something.
0 · Reply
50bps
50bps Jan. 28 at 10:33 PM
$AXS headline numbers look strong
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jan. 28 at 9:50 PM
$AXS Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $3.73 up 8.75% YoY • Reported revenue of $1.73B up 17.85% YoY
0 · Reply
Estimize
Estimize Jan. 28 at 4:00 PM
$AXS reports after the close, Estimize Consensus +0.16 EPS and +15.74M Revs compared to WS http://www.estimize.com/axs/fq4-2025?utm_content
0 · Reply
theGreenerGoblin
theGreenerGoblin Jan. 27 at 6:55 AM
$AXS.X I'm LEGIT about to get down on one knee and marry $AXS.
0 · Reply
StockIt21
StockIt21 Jan. 23 at 5:00 PM
$BTC.X $AXS $SKR.X Seeker Solana Snartphone Token $ELSA.X New on Coinbase $BIO $FUN1.X (Sport. Fun) Prediction Market Sports, Fantasy, NFL Super Bowl Incoming & FIFA High Watch Alert ⚠️ 📢 TOP MOMENTUM & TRENDING GAINERS!!! Bitcoin moving on Gold/Silver All-Time Highs Total Crypto Market Rebounding!!! Follow the Trends: A.I., Technology, ZKP, Science Tech, Predictions Markets (Sports, Politics, Etc), DeFi/De-Sci Know Who You Follow Know What You Own
0 · Reply
JeffreyAppel185
JeffreyAppel185 Jan. 20 at 4:28 PM
$AXS draws attention as investors watch insurance, risk management, and specialty underwriting trends. AITX CEO Steve Reinharz reinforced disciplined execution and improving financial performance in the January 17 update. https://aitx.ai/press-releases/steve-reinharz-breaks-down-q3-results-progress-global-demand-and-the-path-ahead
0 · Reply
Estimize
Estimize Jan. 19 at 11:03 AM
Wall St is expecting 3.11 EPS for $AXS Q4 [Reporting 01/28 AMC] http://www.estimize.com/intro/axs?chart=historical&metric_name=eps&utm_cont
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 15 at 9:11 PM
$AXS RSI: 22.37, MACD: -0.7011 Vol: 3.45, MA20: 105.35, MA50: 102.61 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 6:58 PM
$AXS is riding high, but is it time to hold your horses? 🐎 AXS shares have surged 20.5% over the past year, outperforming its industry by a wide margin of 11%, and it's trading above key moving averages. Yet, with muted analyst sentiment and a Zacks Rank #3 (Hold), caution might be wise. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2811369/axs-stock-moves-above-50-200-day-sma-buy-sell-or-stay-invested?cid=sm-stocktwits-2-2811369-body-27225&ADID=SYND_STOCKTWITS_TWEET_2_2811369_BODY_27225
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 5:58 PM
$AXS clears both the 50 & 200-day SMA — technical breakout or head fake? 👀 The stock is trading above key moving averages as its specialty lines strategy drives gains, but a muted earnings outlook is keeping the bull case in check. Buy, sell, or stay patient? Full breakdown here 👉 https://www.zacks.com/stock/news/2811369/axs-stock-moves-above-50-200-day-sma-buy-sell-or-stay-invested?cid=sm-stocktwits-2-2811369-teaser-27216&ADID=SYND_STOCKTWITS_TWEET_2_2811369_TEASER_27216
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 26 at 11:36 PM
$AXS Current Stock Price: $108.99 Contracts to trade: $110 AXS Jan 16 2026 Call Entry: $0.10 Exit: $0.18 ROI: 79% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ZacksResearch
ZacksResearch Dec. 26 at 3:10 PM
$PLMR is on a tear — up 29.3% in the past year outperforming $TRV, $WRB, and $AXS! With a 51.2% projected EPS increase for 2025 YoY and a Zacks Rank #2 (Buy), PLMR is riding high above its 50-day and 200-day SMAs. Analysts are bullish, as estimates for 2025 and 2026 earnings have risen by 5.6% and 2.5% in the past 60 days. See what makes the investment case strong for PLMR 👉 https://www.zacks.com/stock/news/2809119/plmr-stock-outperforms-industry-what-should-investors-do-now?cid=sm-stocktwits-2-2809119-body-26425&ADID=SYND_STOCKTWITS_TWEET_2_2809119_BODY_26425
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 12:01 PM
$AXS RSI: 85.66, MACD: 2.6915 Vol: 3.90, MA20: 103.72, MA50: 99.27 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Dec. 17 at 6:02 PM
Insurance names quietly setting up for 2026 outperformance? 👀 $TRV, $AXS, $JXN, $LNC and $GL have already outperformed in 2025 — and the setup points to strong returns in 2026 as well. This isn’t hype; it’s momentum backed by real performance. See which insurance stocks could be secure plays for 2026 👉 https://www.zacks.com/stock/news/2805812/5-insurance-stocks-that-can-be-secure-investments-for-2026?cid=sm-stocktwits-2-2805812-teaser-25282&ADID=SYND_STOCKTWITS_TWEET_2_2805812_TEASER_25282
0 · Reply